This page contains a Flash digital edition of a book.
stipulated that her claim could be reason- ably valued at $3,040,708.18. Medicaid’s outlay was $215,645.30. The parties also stipulated that $35,581.47 of the settle- ment was attributable to reimbursement for medical payments made. The Court noted the Federal statute


limiting States to enforcing “rights ... to payment for medical care from any third party,” Id., at 1761, quoting 42 U.S.C. § 1396k(a)(1) (A)(emphasis added), and on the flip side the general limitation on Medicaid recovery except as otherwise provided – from real property or from a probate estate after death. In light of this, it concluded, Medicaid subroga- tion claims are “limited to payments for medical care,” and may not attach or encumber “the remainder of the settlement.” Id. at 1763. The Court spoke disapprovingly of older cases that re- jected “equitable subrogation principles such as the ‘made whole’ rule,” and while its approach was to avoid rather than


reject them, the effect is to strike off in a parallel direction. To be sure, the Court appears to say that to the extent there is a recovery for medical expenses, Federal law “requires ... that the State [Medicaid program] be paid first out of any dam- ages representing payments for medical care before the recipient can recover any of her own costs for medical care.” Id. at 1762. But its direct causation approach is plainly a significant limit on what Med- icaid may claim, even if it won’t resolve every aspect of every case favorably for injured plaintiffs. The Court noted at the outset that


everyone agreed that a litigated deter- mination of allocation, whether by judge or jury, would be binding, Id. at 1762, and dismissed as solvable the potential problem – not presented in that case be- cause of the parties’ stipulation – of how to determine allocation in the context of settlements. The risk of post-settlement manipulation is easily solved, it said. The


State Medicaid program agrees to an al- location or the issue can be submitted to the court. In any event, the Court said, there is as much to be concerned with over-allocation as under-allocation, “unfair to the recipients” in the former situation. Also, it cited with approval AAJ’s observation in its amicus brief that some States have methods for al- locating tort settlements where private insurers are also involved. This appears to be a back-door ap-


proval of equitable contribution. As in Ahlborn itself, a settlement that reflects a discount on reasonably claimed losses because of all of the many risks of liti- gation should affect how much of the recovery is attributed to medical costs as it is to any other element of dam- ages. That is exactly where subsequent cases have gone. See, e.g., Lugo ex rel. Lugo v. Beth Israel Medical Center, 819 N.Y.S.2d 892, 13 Misc.3d 681, 2006 N.Y. Slip Op. 26340 (N.Y.Sup. Jul 21, 2006).


TM RINGLER ASSOCIATES


STRUCTURED S The Only Broker


Lou Omansky, J.D., CSSC LOmansky@ringlerassociates.com


ETTLEMENTS You Need


TM


Richard Ryan, CSSC RRyan@ringlerassociates.com


Designing and implementing structured settlements for injured parties since 1975


Our focus is on achieving the best possible results for all parties in settlement negotiations using tax–free settlement annuities.


Offering the most competitive annuity prices from all of the leading life insurance companies


We are one of the few companies that truly enjoys the trust of all parties involved in the settlement process.


410-602-1042  410-602-1101 Fax 4 Reservoir Circle  Suite 101  Baltimore, Maryland  21208 42 Trial Reporter Fall 2008 TM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76